Clinical Trial Update: This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours) [Phase 1]

View source ↗

Summary

Phase 1 trial update for BI 905677 in various solid tumors; study terminated with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• BI 905677

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2024-03-04